Wuhan Hiteck Biological Pharma Co.,Ltd
Status: Publicly traded
Direct answer
Wuhan Hiteck Biological Pharma Co.,Ltd is publicly traded on SHZ under the ticker 300683.SZ.
Wuhan Hiteck Biological Pharma Co.,Ltd is a biopharmaceutical enterprise operating in China, primarily engaged in the research, development, manufacturing, and commercialization of bio-engineered products and lyophilized injectable medications. The company's extensive product portfolio encompasses a variety of pharmaceutical solutions, such as Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium...
Can you invest in Wuhan Hiteck Biological Pharma Co.,Ltd?
Yes. Wuhan Hiteck Biological Pharma Co.,Ltd trades publicly on SHZ as 300683.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Wuhan Hiteck Biological Pharma Co.,Ltd
Detailed equity research is provided by MarketSnap.